{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:27:06Z","timestamp":1778074026195,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.autrev.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T21:37:45Z","timestamp":1551303465000},"page":"325-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis"],"prefix":"10.1016","volume":"18","author":[{"given":"Ga\u00eblle","family":"Dzangu\u00e9-Tchoupou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuberaka","family":"Mariampillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efs","family":"Bolko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Amelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wladimir","family":"Mauhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lien","family":"Corneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.autrev.2019.02.003_bb0005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.autrev.2017.07.021","article-title":"Using multi-omics methods to understand dermatomyositis\/polymyositis","volume":"16","author":"Gao","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.003_bb0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.autrev.2017.05.003","article-title":"Integrated diagnosis project for inflammatory myopathies: an association between autoantibodies and muscle pathology","volume":"16","author":"Suzuki","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2019.02.003_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.003_bb0020","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.clinph.2015.12.011","article-title":"Sporadic inclusion body myositis: a review of recent clinical advances and current approaches to diagnosis and treatment","volume":"127","author":"Needham","year":"2016","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.003_bb0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/acn3.419","article-title":"Immune and myodegenerative pathomechanisms in inclusion body myositis","volume":"4","author":"Keller","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"10.1016\/j.autrev.2019.02.003_bb0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.autrev.2017.07.016","article-title":"How I treat idiopathic patients with inflammatory myopathies in the clinical practice","volume":"16","author":"Cavagna","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"Pt 11","key":"10.1016\/j.autrev.2019.02.003_bb0035","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain J Neurol."},{"issue":"5","key":"10.1016\/j.autrev.2019.02.003_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken","volume":"129","author":"Benveniste","year":"2015","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.003_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-3083.2003.01251.x","article-title":"Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time","volume":"58","author":"M\u00fcntzing","year":"2003","journal-title":"Scand J Immunol"},{"issue":"17","key":"10.1016\/j.autrev.2019.02.003_bb0050","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000265398.77681.09","article-title":"T cell receptor profiling in muscle and blood lymphocytes in sporadic inclusion body myositis","volume":"69","author":"Salajegheh","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.003_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.autrev.2016.09.019","article-title":"Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies","volume":"16","author":"Day","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.003_bb0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.autrev.2017.12.005","article-title":"Skeletal muscle cells actively shape (auto)immune responses","volume":"17","author":"Afzali","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088788","article-title":"Th1 response and systemic treg deficiency in inclusion body myositis","volume":"9","author":"Allenbach","year":"2014","journal-title":"PloS One."},{"key":"10.1016\/j.autrev.2019.02.003_bb0070","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/brain\/aww024","article-title":"Association of inclusion body myositis with T cell large granular lymphocytic leukaemia","volume":"139","author":"Greenberg","year":"2016","journal-title":"Brain J Neurol"},{"issue":"11","key":"10.1016\/j.autrev.2019.02.003_bb0075","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1002\/art.27665","article-title":"Expanded T cell receptor V\u03b2-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells","volume":"62","author":"Pandya","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.003_bb0080","first-page":"3207","article-title":"Differential localization of T-bet and eomes in CD8 T cell memory populations","volume":"190","author":"McLane","year":"2013","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.autrev.2019.02.003_bb0085","first-page":"5","article-title":"Characterization of T-bet and eomes in peripheral human immune cells","author":"Knox","year":"2014","journal-title":"Front Immunol [Internet]"},{"issue":"8","key":"10.1016\/j.autrev.2019.02.003_bb0090","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"6111","key":"10.1016\/j.autrev.2019.02.003_bb0095","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1229620","article-title":"Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection","volume":"338","author":"Paley","year":"2012","journal-title":"Science"},{"issue":"39","key":"10.1016\/j.autrev.2019.02.003_bb0100","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.003_bb0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.2046","article-title":"Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection","volume":"12","author":"Kao","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2019.02.003_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/labmed\/lmw053","article-title":"CD127 expression in naive and memory T cells in HIV patients who have undergone long-term HAART","volume":"48","author":"Xu","year":"2017","journal-title":"Lab Med"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101441","article-title":"CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV\/HIV co-infected individuals","volume":"9","author":"Kared","year":"2014","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.autrev.2019.02.003_bb0120","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1182\/blood-2002-07-2103","article-title":"Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells","volume":"101","author":"Brenchley","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.autrev.2019.02.003_bb0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.autrev.2019.02.003_bb0130","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.immuni.2013.05.009","article-title":"Effector-like CD8+ T cells in the memory population mediate potent protective immunity","volume":"38","author":"Olson","year":"2013","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.autrev.2019.02.003_bb0135","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.20030916","article-title":"CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool","volume":"198","author":"Hendriks","year":"2003","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.003_bb0140","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.003_bb0145","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ana.23840","article-title":"Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis","volume":"73","author":"Larman","year":"2013","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.003_bb0150","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","article-title":"Advances in serological diagnostics of inflammatory myopathies","volume":"29","author":"Benveniste","year":"2016","journal-title":"Curr Opin Neurol"},{"issue":"11","key":"10.1016\/j.autrev.2019.02.003_bb0155","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1212\/01.wnl.0000187124.92826.20","article-title":"Plasma cells in muscle in inclusion body myositis and polymyositis","volume":"65","author":"Greenberg","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.003_bb0160","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/nan.12149","article-title":"Mitochondrial and inflammatory changes in sporadic inclusion body myositis","volume":"41","author":"Rygiel","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6030","key":"10.1016\/j.autrev.2019.02.003_bb0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","article-title":"Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum","volume":"332","author":"Bendall","year":"2011","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.autrev.2019.02.003_bb0170","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1158\/2159-8290.CD-15-0298","article-title":"Mass cytometric functional profiling of acute myeloid leukemia defines cell-cycle and Immunophenotypic properties that correlate with known responses to therapy","volume":"5","author":"Behbehani","year":"2015","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.autrev.2019.02.003_bb0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nprot.2015.020","article-title":"Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm","volume":"10","author":"Zunder","year":"2015","journal-title":"Nat Protoc"},{"issue":"3","key":"10.1016\/j.autrev.2019.02.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194593","article-title":"Analysis of cell surface and intranuclear markers on non-stimulated human PBMC using mass cytometry","volume":"13","author":"Dzangu\u00e9-Tchoupou","year":"2018","journal-title":"PloS One."},{"issue":"12","key":"10.1016\/j.autrev.2019.02.003_bb0185","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/cyto.a.22573","article-title":"Transient partial permeabilization with saponin enables cellular barcoding prior to surface marker staining","volume":"85","author":"Behbehani","year":"2014","journal-title":"Cytom Part J Int Soc Anal Cytol"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.003_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000000642","article-title":"Evaluation and construction of diagnostic criteria for inclusion body myositis","volume":"83","author":"Lloyd","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.autrev.2019.02.003_bb0195","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord NMD"},{"key":"10.1016\/j.autrev.2019.02.003_bb0200","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-mediated necrotizing myopathies working group. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord NMD. 2018 (Jan;28(1):87\u201399)."},{"issue":"4","key":"10.1016\/j.autrev.2019.02.003_bb0205","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.24902","article-title":"Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies","volume":"81","author":"Arouche-Delaperche","year":"2017","journal-title":"Ann Neurol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997219300291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:16:04Z","timestamp":1761599764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997219300291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1568997219300291"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2019.02.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}